Stent :: Swedish registry results of drug-eluting stents

Boston Scientific Corporation (NYSE: BSX) today commented on results from a Swedish registry assessing the long-term outcomes of drug-eluting stents (DES) versus bare- metal stents (BMS) that were released online today and are scheduled for publication in the March 8th edition of the New England Journal of Medicine.

Stent :: Efficacy of the CYPHER Sirolimus eluting coronary stent confirmed

The long-term safety of the CYPHER(R) Sirolimus-eluting Coronary Stent, specifically in terms of death, myocardial infarction (heart attacks) and stent thrombosis (also known as blood clots), is comparable to that of bare metal stents when used according to product labeling, according to a variety of studies appearing today in the New England Journal of Medicine (NEJM).

Smoking :: Intense cessation treatment proves successful in high-risk smokers

New research published in the February issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), suggests that high-risk smokers with acute cardiovascular disease are three to four times more likely to quit smoking when treated with an intensive smoking cessation program.

Health Care :: Biosensors at the bedside could revolutionize health care

In hospitals today, the first warning that a post-operative patient is going into septic shock is often when the patient’s blood pressure collapses and congestive heart failure begins. By that time the patient has a high probability of dying, or if he survives, an even higher probability of permanent major organ damage after a long stay in an intensive care unit.

Tobacco :: Adults support r-rating for movies showing tobacco

According to a new survey, 81 percent of adults in the United States agree adolescents are more likely to smoke if they watch actors smoke in movies. Also, 70 percent support a new R-rating for any movies with on-screen tobacco imagery, unless the film clearly demonstrates the dangers of smoking.

Atrial Fibrillation :: Surgeons develop simpler way to cure atrial fibrillation

Physicians have an effective new option for treating atrial fibrillation, a common irregular heart rhythm that can cause stroke. Heart surgeons at Washington University School of Medicine in St. Louis have developed and tested a device that radically shortens and simplifies a complex surgical procedure that has had the best long-term cure rate for persistent atrial fibrillation.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack